Running from behind

Running from behind

Yes, the love affair with closed loop insulin delivery systems is in full bloom in Paris, a city known for more than a few love stories. Today it was Insulet’s (NASDAQ: PODD) turn to show off releasing results from early study data for their Omnipod Horizon™ hybrid closed-loop system.  Per a company issued press release . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.